| MGLCX | MGLKX | MGLCX / MGLKX | |
| Total Expense Ratio | 1.93 | 1.43 | 135% |
| Annual Report Gross Expense Ratio | 1.94 | 1.44 | 135% |
| Fund Existence | 12 years | 12 years | - |
| Gain YTD | 11.001 | 11.262 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.2B | 2.2B | 100% |
| Annual Yield % from dividends | 1.88 | 2.49 | 76% |
| Returns for 1 year | 11.44 | 11.97 | 96% |
| Returns for 3 years | 18.64 | 20.36 | 92% |
| Returns for 5 years | -10.59 | -8.32 | 127% |
| Returns for 10 years | 17.84 | 25.12 | 71% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EIPI | 22.23 | 0.08 | +0.36% |
| FT Energy Income Ptnrs Enh Inc ETF | |||
| CPNJ | 27.52 | 0.02 | +0.07% |
| Calamos Nasdaq-100 Str Alt Prt ETF-Jun | |||
| USTB | 50.63 | N/A | N/A |
| VictoryShares Short-Term Bond ETF | |||
| BGT | 10.61 | -0.03 | -0.28% |
| BlackRock Floating Rate Income Trust | |||
| BBC | 53.92 | -0.28 | -0.51% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||